Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SolarEdge Technologies Q3 EPS $1.45 Beats $1.36 Estimate, Sales $526.40M Miss $529.99M Estimate

SolarEdge Technologies (NASDAQ:SEDG) reported quarterly earnings of $1.45 per share which beat the analyst consensus estimate of $1.36 by 6.62 percent. This is a 19.83 percent increase over earnings of $1.21 per share
byBenzinga Newsdesk
November 2, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

SolarEdge Technologies (NASDAQ:SEDG) reported quarterly earnings of $1.45 per share which beat the analyst consensus estimate of $1.36 by 6.62 percent. This is a 19.83 percent increase over earnings of $1.21 per share from the same period last year. The company reported quarterly sales of $526.40 million which missed the analyst consensus estimate of $529.99 million by 0.68 percent. This is a 55.70 percent increase over sales of $338.10 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Alterity Therapeutics Announced Monday, Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer’s Disease

By Charles Gross
Today, 11:55 PM
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) announced that the composition of matter patent previously allowed by the United States Patent and Trademark Office (USPTO) has now been granted. The patent, entitled "Compounds for and methods of treating diseases" (No. 11,603,364), covers more than 100 novel compounds with an acyl hydrazone (AH) structure and provides 20 years of exclusivity.

ATHE